NEW DELHI : Indian experts are investigating if there are any domestic cases of blood clotting—even mild ones —as a side effect of the two covid-19 vaccines being administered in India, two people aware of the development said.
At over 83 million, AstraZeneca’s Covishield vaccine accounts for 90% of the doses administered in India so far. The remaining 8.1 million doses are of Bharat Biotech International’s Covaxin.
